Sara Montecchini

Dr. Sara Montecchini

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Mirko ButtriniMirko Buttrini
Mirko Buttrini
BFBenedetta Farina
Benedetta Farina
Sara MontecchiniSara Montecchini
Sara Montecchini
FCFlora De Conto
Flora De Conto
CCCarlo Chezzi
Carlo Chezzi
Respiratory tract infections (RTIs) are the focus of developments in public health, given their widespread distribution and the high morbidity and mortality rates reported worldwide. The clinical spectrum ranges from asymptomatic or mild infection to severe or fatal disease. Rapidity is required in diagnostics to provide adequate and prompt management of patients. The current algorithm for the laboratory diagnosis of RTIs relies on multiple approaches including gold-standard conventional methods, among which the traditional culture is the most used, and innovative ones such as molecular methods, mostly used to detect viruses and atypical bacteria. The implementation of molecular methods with syndromic panels has the potential to be a powerful decision-making tool for patient management despite requiring appropriate use of the test in different patient populations. Their use radically reduces time-to-results and increases the detection of clinically relevant pathogens compared to conventional methods. Moreover, if implemented wisely and interpreted cautiously, syndromic panels can improve antimicrobial use and patient outcomes, and optimize laboratory workflow. In this review, a narrative overview of the main etiological, clinical, and epidemiological features of RTI is reported, focusing on the laboratory diagnosis and the potentialities of syndromic panels.

13 September 2013 in Malaria Journal
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
GPGiovanna Piccolo
Giovanna Piccolo
CGChiara Gorrini
Chiara Gorrini
SRSabina Rossi
Sabina Rossi
Sara MontecchiniSara Montecchini
Sara Montecchini
Maria-Cristina ArcangelettiMaria-Cristina Arcangeletti
Maria-Cristina Arcangeletti
Accurate identification of Plasmodium infections in non-endemic countries is of critical importance with regard to the administration of a targeted therapy having a positive impact on patient health and management and allowing the prevention of the risk of re-introduction of endemic malaria in such countries. Malaria is no longer endemic in Italy where it is the most commonly imported disease, with one of the highest rates of imported malaria among European non-endemic countries including France, the UK and Germany, and with a prevalence of 24.3% at the University Hospital of Parma. Molecular methods showed high sensitivity and specificity and changed the epidemiology of imported malaria in several non-endemic countries, highlighted a higher prevalence of Plasmodium ovale, Plasmodium vivax and Plasmodium malariae underestimated by microscopy and, not least, brought to light both the existence of two species of P. ovale (Plasmodium ovale curtisi and Plasmodium ovale wallikeri) and the infection in humans by Plasmodium knowlesi, otherwise not detectable by microscopy.

16 May 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Sara MontecchiniSara Montecchini
Sara Montecchini
SRSabina Rossi
Sabina Rossi
CGChiara Gorrini
Chiara Gorrini
FCFlora De Conto
Flora De Conto
Maria-Cristina ArcangelettiMaria-Cristina Arcangeletti
Maria-Cristina Arcangeletti
The aim of this study was to assess the epidemiology of intestinal parasitoses during a 5-year period in patients attending a tertiary-care hospital in a non-endemic setting.

Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
FMFederica Motta
Federica Motta
Sara MontecchiniSara Montecchini
Sara Montecchini
CGChiara Gorrini
Chiara Gorrini
GPGiovanna Piccolo
Giovanna Piccolo
FCFlora De Conto
Flora De Conto
Despite that matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) has become a powerful tool in the clinical microbiology setting, few studies have till now focused on MALDI-TOF MS-based identification of dermatophytes. In this study, we analyze dermatophytes strains isolated from clinical samples by MALDI-TOF MS to supplement the reference database available in our laboratory. Twenty four dermatophytes (13 reference strains and 11 field isolated strains), identified by both conventional and molecular standard procedures, were analyzed by MALDI-TOF MS, and the spectra obtained were used to supplement the available database, limited to a few species. To verify the robustness of the implemented database, 64 clinical isolates other than those used for the implementation were identified by MALDI-TOF MS. The implementation allowed the identification of the species not included in the original database, reinforced the identification of the species already present and correctly identified those within the Trichophyton mentagrophytes complex previously classified as Trichophyton. tonsurans by MALDI-TOF MS. The dendrogram obtained by analyzing the proteic profiles of the different species of dermatophytes reflected their taxonomy, showing moreover, in some cases, a different clusterization between the spectra already present in the database and those newly added. In this study, MALDI-TOF MS proved to be a useful tool suitable for the identification of dermatophytes for diagnostic purpose.

4 January 2018 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
Mirko ButtriniMirko Buttrini
Mirko Buttrini
Sara MontecchiniSara Montecchini
Sara Montecchini
SRSabina Rossi
Sabina Rossi
GPGiovanna Piccolo
Giovanna Piccolo
FCFlora De Conto
Flora De Conto
In this study for the first time, a Dientamoeba fragilis protein profile by MALDI-TOF MS was created in order to identify specific markers for the application of this technology in the laboratory diagnosis of dientamoebiasis. In particular, one D. fragilis reference strain was used to create a reference spectrum and 14 clinical isolates to verify the reliability of the obtained results. While 15 peaks were found to be discriminating between the reference strain and the culture medium used, six peaks, observed in all the 14 strains tested, were considered as markers able to identify D. fragilis. In our hands, MALDI-TOF MS technology was demonstrated as a useful tool to be used in association with or in replacement of the real-time PCR assay for the identification of D. fragilis used in our laboratory on xenic cultures, due to its accuracy, rapidity and low cost.

2 June 2014 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Adriana CalderaroAdriana Calderaro
Adriana Calderaro
GPGiovanna Piccolo
Giovanna Piccolo
CGChiara Gorrini
Chiara Gorrini
Sara MontecchiniSara Montecchini
Sara Montecchini
Mirko ButtriniMirko Buttrini
Mirko Buttrini
MMMaria Cristina Medici
Maria Cristina Medici
Leptospirosis, a spirochaetal zoonotic disease of worldwide distribution, endemic in Europe, has been recognized as an important emerging infectious disease, though yet it is mostly a neglected disease which imparts its greatest burden on impoverished populations from developing countries. Leptospirosis is caused by the infection with any of the more than 230 serovars of pathogenic Leptospira sp. In this study we aimed to implement the MALDI-TOF mass spectrometry (MS) database currently available in our laboratory with Leptospira reference pathogenic (L. interrogans, L. borgpetersenii, L. kirschneri, L. noguchii), intermediate (L. fainei) and saprophytic (L. biflexa) strains of our collection in order to evaluate its possible application to the diagnosis of leptospirosis and to the typing of strains. This was done with the goal of understanding whether this methodology could be used as a tool for the identification of Leptospira strains, not only at species level for diagnostic purposes, but also at serovar level for epidemiological purposes, overcoming the limits of serological and molecular conventional methods. Twenty Leptospira reference strains were analysed by MALDI-TOF MS. Statistical analysis of the protein spectra was performed by ClinProTools software.